Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-Q/A, Date: 2011-03-15
Original SEC Filing: Click here

---

Webplus: CPHI/20110315/10-Q.A_4/1/000.htm SEC Original: cphi10qa063010.htm
FORM 10-Q/A (Amendment No. 1) (Mark One) x June 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer’s telephone number,

---

---

Webplus: CPHI/20110315/10-Q.A_4/2_EX-31.1/000.htm SEC Original: cphi10qaex311063010.htm
CERTIFICATION I, Zhilin Li, certify that: 1. I have reviewed this Amendment No. 1 to Form 10-Q for the quarter ended June 30, 2010 of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in

---

---

Webplus: CPHI/20110315/10-Q.A_4/3_EX-31.2/000.htm SEC Original: cphi10qaex312063010.htm
CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this Amendment No. 1 on Form 10-Q for the quarter ended June 30, 2010 of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in

---

---

Webplus: CPHI/20110315/10-Q.A_4/4_EX-32.1/000.htm SEC Original: cphi10qaex321063010.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: March 15, 2011 ——————————– President and Chief Executive Officer EX-32.1 4 cphi10qaex321063010.htm

---

---

Webplus: CPHI/20110315/10-Q.A_4/5_EX-32.2/000.htm SEC Original: cphi10qaex322063010.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: March 15, 2011 ——————— (principal financial officer and principal accounting officer) EX-32.2 5 cphi10qaex322063010.htm

---

Company Information:

Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-Q/A, Date: 2011-03-15CIK: 0001106644, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
2ND FLOOR, NO. 17, JINPAN ROAD, HAIKOU
HAINAN PROVINCE 570216